跳至主要内容
临床试验/JPRN-UMIN000022219
JPRN-UMIN000022219已完成未知

Effect of ingestion of reduced coenzyme Q10 in patients with mild cognitive impairment - Effect of ingestion of reduced coenzyme Q10 in patients with mild cognitive impairment

KAKU Neurosurgery clinic0 个研究点目标入组 50 人开始时间: 2016年5月9日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50years-old 至 89years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1) A score of 19 or less on the Revised Hasegawa Dementia Scale (HDS-R) (2) Diagnosis of Parkinson's disease, Huntington's disease, multiple sclerosis, or epilepsy or the presence of head trauma (3) Diagnosis of schizophrenia, depression, or serious heart disorder; incomplete recovery from a malignancy; or ongoing dialysis (4) Treatment with oxidized coenzyme Q10 or reduced coenzyme Q10 within the last 2 months (5) Judgment by the investigator as being ineligible to be a study subject for any other reason

研究者

发起方
KAKU Neurosurgery clinic

相似试验